Peking University People's Hospital, Peking Univeristy Hepatology Institute, 11# Xizhimen South Street, Xicheng district, Beijing 100044, PR China.
Virus Res. 2010 Jun;150(1-2):129-34. doi: 10.1016/j.virusres.2010.03.005. Epub 2010 Mar 18.
The nucleocapsids formation is a pivotal step of hepatitis B virus (HBV) life cycle. The inhibition of HBV nucleocapsids assembly is a promising strategy for the anti-HBV treatment. HBc78-117 is an internal fragment of hepatitis B core protein (HBc). In this study, we used lentiviral vector to deliver HBc78-117 cDNA sequence into HepG2.2.15 cells and examined the effect of HBc78-117 on HBV replication. We confirmed by immunoprecipitation analysis that HBc78-117 interacted with full-length HBc in HepG2.2.15 cells. The nucleocapsids and HBV DNA replication intermediates were markedly reduced in the cells expressing HBc78-117, although HBV pregenome RNA was not affected. The level of HBV DNA was also significantly reduced in culture supernatant. These suggest that HBc78-117 can inhibit HBV DNA replication by interfering with nucleocapsids assembly.
核衣壳形成是乙型肝炎病毒 (HBV) 生命周期的关键步骤。抑制 HBV 核衣壳组装是一种有前途的抗 HBV 治疗策略。HBc78-117 是乙型肝炎核心蛋白 (HBc) 的内部片段。在这项研究中,我们使用慢病毒载体将 HBc78-117 cDNA 序列递送至 HepG2.2.15 细胞,并检查了 HBc78-117 对 HBV 复制的影响。我们通过免疫沉淀分析证实 HBc78-117 在 HepG2.2.15 细胞中与全长 HBc 相互作用。尽管 HBV 前基因组 RNA 不受影响,但表达 HBc78-117 的细胞中的核衣壳和 HBV DNA 复制中间体明显减少。HBV DNA 的水平在培养上清液中也显著降低。这些表明 HBc78-117 可以通过干扰核衣壳组装来抑制 HBV DNA 复制。